(To read more on the industrial market, click here.)

DEVENS, MA-Bristol-Myers Squibb Co. has completed the $3.6-million purchase of 89 acres from MassDevelopment. The new owner will begin constructing a $660-million biologics manufacturing facility on the site of the former Fort Devens military base within the next few weeks, a spokesman for the company tells GlobeSt.com.

The project's first phase will include 400,000 sf of lab, office and manufacturing space along with six 20-liter bioreactors and one purification train that will allow the firm to begin producing commercial biologic compounds and help meet the needs of other biologic compounds Bristol-Myers Squibb is currently developing, the spokesman says.

Designed by Fluor Enterprises of Greenville SC, the facility, which is expected to encompass 1.5 million sf, will be fully operational by 2009 for research and validation purposes but won't actually begin producing biologic drugs for commercial use until it receives FDA approvals, he added. The facility is expected to receive FDA approvals in 2010, he says.